UNC5C (Unc-5 Netrin Receptor C) encodes a transmembrane receptor for the axon guidance molecule netrin-1. This receptor plays critical roles in neuronal development, synaptic plasticity, and has been identified as a susceptibility gene for Alzheimer's disease. UNC5C-mediated signaling influences axonal guidance during development, maintains synaptic connectivity in the adult brain, and its dysfunction contributes to neurodegenerative processes.
| Attribute | Value |
|---|---|
| Gene Symbol | UNC5C |
| Full Name | Unc-5 Netrin Receptor C |
| Chromosomal Location | 4q32.3 |
| NCBI Gene ID | 4923 |
| OMIM | 607023 |
| Ensembl ID | ENSG00000144642 |
| UniProt ID | Q9ULS4 |
| Gene Type | Protein coding |
| Associated Diseases | Alzheimer's Disease, Huntington's Disease |
UNC5C is a member of the UNC-5 family of netrin receptors with a complex multi-domain structure:
Extracellular Domain:
Transmembrane Domain:
Intracellular Domain:
UNC5C activates multiple downstream signaling cascades:
During development, UNC5C functions as a repulsive axon guidance receptor:
In the adult brain, UNC5C maintains synaptic integrity:
Synaptic Plasticity:
Synaptic Maintenance:
UNC5C-mediated signaling promotes neuronal health:
UNC5C shows region-specific expression:
UNC5C is a confirmed AD susceptibility gene with multiple lines of evidence:
Genetic Evidence:
Mechanistic Links to AD:
Synaptic Dysfunction: UNC5C variants contribute to synaptic loss by disrupting netrin-1 signaling that maintains synaptic integrity. The netrin-1/UNC5C pathway is essential for synaptic maintenance, and its disruption accelerates synaptic degeneration.
Axonal Degeneration: Impaired UNC5C signaling disrupts cytoskeletal dynamics, leading to axonal dystrophy and degeneration. This is particularly relevant to the "dying-back" pattern of neurodegeneration observed in AD.
Tau Pathology: UNC5C dysfunction interacts with tau phosphorylation pathways. Studies show that UNC5C variants exacerbate tau pathology, potentially linking synaptic vulnerability to the spread of tau pathology.
Amyloid-beta Toxicity: UNC5C mediates Aβ-induced synaptic toxicity. The receptor may serve as a conduit through which Aβ oligomers exert their synaptotoxic effects.
Network Dysfunction: Reduced netrin-1/UNC5C signaling contributes to the disconnection syndrome observed in AD brains, with disruption of connectivity between brain regions.
UNC5C is implicated in HD through:
Multiple UNC5C variants have been associated with disease:
Netrin-1 agonists: Small molecules or peptides that enhance netrin-1/UNC5C signaling could protect synapses
Downstream signaling modulators: Targeting PI3K/Akt or other effectors to bypass receptor dysfunction
Gene therapy: Viral vector delivery of functional UNC5C variants
Protein aggregation inhibitors: Addressing downstream effects of UNC5C dysfunction
UNC5C expression is dynamically regulated by DNA methylation:
Chromatin architecture influences UNC5C transcription:
Multiple microRNAs regulate UNC5C:
UNC5C interacts with multiple proteins:
| Interactor | Interaction Type | Functional Consequence |
|---|---|---|
| Netrin-1 | Ligand binding | Activation of downstream signaling |
| DCC | Co-receptor | Netrin-1 shared signaling |
| Unc-5H1/H2/H4 | Homologs | Potential heterodimerization |
| PTPD1 | Phosphatase binding | Dephosphorylation events |
| LRRK2 | Kinase interaction | Phosphorylation regulation |
| P53 | Transcription factor | Pro-apoptotic signaling |
UNC5C forms multi-protein signaling complexes:
The UNC5C extracellular region contains:
N-terminal Domains:
Netrin-1 Binding:
Death Domain (DD):
Zinc-binding Domain (ZBD):
Proline-rich Region:
Ligand binding induces structural rearrangements:
| Approach | Development Stage | Description | Challenges |
|---|---|---|---|
| Netrin-1 agonists | Preclinical | Enhance UNC5C signaling | BBB penetration |
| Small molecule modulators | Research | Target downstream pathways | Selectivity |
| Gene therapy | Preclinical | Restore functional UNC5C | Viral delivery |
| Protein replacement | Research | Recombinant UNC5C protein | Stability |
Expression Biomarkers:
Therapeutic Monitoring:
No current clinical trials specifically targeting UNC5C in neurodegeneration. Related efforts:
| Model | Background | Modification | Phenotype |
|---|---|---|---|
| UNC5C KO | C57BL/6 | Complete knockout | Viable, neurological deficits |
| UNC5C flox | C57BL/6 | Conditional deletion | Tissue-specific KO |
| UNC5C Tg | C57BL/6 | Overexpression | Protected phenotype |
| UNC5C point mutants | Various | Site-directed | Functional analysis |
Alzheimer's Disease Models:
Aging Studies:
Behavioral Testing:
Neuroanatomical Analysis:
UNC5C occupies a central position in neuronal signaling networks:
UNC5C Signaling Network
┌─────────────┐
│ Neuronal │
│ Survival │
└──────┬──────┘
│
┌──────────────┐ ┌──────▼──────┐
│ Apoptosis │◀─────▶│ PI3K/Akt │
│ Regulation │ │ Pathway │
└──────┬───────┘ └──────▲──────┘
│ │
│ ┌───────┴───────┐
│ │ │
▼ ▼ ▼
┌─────────────────┐ ┌──────────┐ ┌─────────────┐
│ Death Domain │ │ Netrin-1 │ │ Cytoskeletal│
│ Signaling │ │ Binding │ │ Regulation │
└─────────────────┘ └──────────┘ └─────────────┘
│
▼
┌─────────────────┐
│ p53 Pathway │
│ Activation │
└─────────────────┘
UNC5C connects to major neuronal pathways:
The UNC5 gene family evolved: